Search Results 4261-4270 of 33392 for oral
TP-0903 is a novel oral inhibitor that targets AXL kinase and reverses the mesenchymal phenotype associated with advanced cancers. TP-0903 has demonstrated ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
Dental care. Seeing a dentist regularly is a big part of oral health. So is taking care of your teeth and gums so they stay healthy. You likely ...
... oral anticoagulant or low molecular weight heparin (LMWH) * Exception: If receiving warfarin, the patient must have an INR =\< 3.0. For heparin and LMWH ...
2016 - 2018. MemberAmerican College of Radiology, Council Steering Committee · 2016 - present. MemberAmerican Board of Radiology, Radiologic Physics Oral Board ...
... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...
... oral polio vaccine, and oral typhoid). At registration, investigator must declare intent-to-treat with residual PET radiation therapy (residual PET RT- RPRT) ...
The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD (cases) as ...
Receiving systemic immunosuppressive therapy (> 2 weeks) including oral steroid doses > 10 mg/day of prednisone or equivalent within 2 months prior to ...
Any acute infection within 30 days prior to randomization that required oral antimicrobial or antiviral therapy. Patients with history of chronic or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.